A Phase 1, Study of the Safety and Tolerability of ALV003 in Healthy Adult Volunteers and Subjects With Well-Controlled Celiac Disease
Completed · Phase 1 · Has a placebo group
Conditions studied: Celiac Disease
In brief
To assess safety and tolerability of ALV003 in healthy volunteers and patients with Celiac Disease
Key facts
- Study ID
- NCT00626184
- Run by
- Alvine Pharmaceuticals Inc.
- People needed
- 28
- Starts
- 2008-02-01
- Expected to finish
- 2008-07-01
- Last updated by the study team
- 2009-08-18
Who can join
Age: 18 and older, up to 45. Sex: any. Healthy volunteers: accepted.
Where it is running
- Clinical Applications Laboratories Inc. — San Diego, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.